10-08-2010

Ben-Gurion University of the Negev (BGU) Professor Ron N. Apte has been awarded the 2010 Samuel and Paula Elkeles Prize for Outstanding Scientist in the Field of Medicine. Professor Apte is chairman of the Shraga Segal Department of Microbiology and Immunology and vice dean of the Basic ...

more

Newly published data confirms long term efficacy, safety and tolerability in treating early Parkinson's disease

09-08-2010

H. Lundbeck A/S and Teva Pharmaceutical Industries Ltd. announced newly published long-term data on Azilect® (rasagiline tablets) from the TEMPO study and its open-label extension. The findings confirm the long-term efficacy, safety and tolerability of Azilect® in patients with Parkinson's ...

more

23-09-2009

A researcher who is working on a vaccine for Alzheimer’s disease (AD) has demonstrated that it is possible to test and measure specific immune responses in mice carrying human genes and to anticipate the immune response in Alzheimer’s patients. This continuing research at Ben-Gurion ...

more

New Tel Aviv University drug cuts off blood supplies to starve cancer tumors

21-09-2009

Like vampires, cancer tumors require an ample supply of blood to stay alive. Without fresh blood for sustenance, cancer cells shrivel up like raisins and die. To that end, Dr. Ronit Satchi-Fainaro of Tel Aviv University's Department of Physiology and Pharmacology, Sackler School of Medicine, ...

more

13-03-2009

Allium Group announced the nomination of the former Director General of Hadassah Medical Organization, Prof. Shmuel Penchas, as a member of the Board of Directors. According to the company, Prof. Penchas' first-time decision to join the board of a stent company reflects his confidence in ...

more